[WorldKings - Wowtimes - Almanac Events & Achievements 2023] Milestones of 77 years of development of Grünenthal GmbH, the company that first introduced penicillin into the German market (1946)

04-07-2023

(worldkings.org) Grünenthal is a pharmaceutical company headquartered in Aachen in Germany. The company forms a small group within the limited partnership group Grünenthal Pharma GmbH & Co., which is wholly owned by members of the Wirtz family.

It was founded in Stolberg (Rhineland) in 1946 and was the first to introduce penicillin into the German market in the postwar period, after the Allied Control Council lifted its ban.

In addition to two branches in Germany, the company has subsidiaries in Europe, Latin America and the United States.

 

The company's milestones:

- In 1946: The Wirtz family founds Chemie Grünenthal GmbH in Stolberg, Germany.

- In 1947: Grünenthal is the first company in Germany to register penicillin after World War II.

- In 1968: Established the first foreign branch in Peru.

- In 1977: Tramal is launched; it has since become one of the most frequently prescribed central acting analgesics worldwide.

 

- In 2001: Transtec, an analgesic for chronic pain, is launched in Europe.

- In 2003: Zaldiar is launched globally as the first fixed-dose analgesic containing paracetamol and a small dose of Tramadol. This product is used for the treatment of acute pain.

- In 2007: Versatis, a topically acting lidocaine patch used for the treatment of neuropathic pain after herpes zoster, is launched in the EU.

- In 2010: First launch of Palexia retard in Europe.

 

- In 2013: Acquired Laboratorios Andrómaco S.A. and expand the business across Andean countries and Central America .

- In 2014: Began to distribute Arcoxia in several European countries.

- In 2017:  Entered into an agreement with AstraZeneca for the global rights to Zomig (Zolmitriptan), excluding Japan, a treatment used for the acute treatment of migraines and cluster headaches..

- In 2018: Acquisition of the pain-related brands Nexium and Vimovo.

- In 2022: Acquisition of the brand Nebido, a testosterone replacement therapy.

According to grunenthal.com, en.wikipedia.org


Chris - (Collect and Edit) - WORLDKINGS (Source of photos: Internet)

 

towerWorldKings journeys
islandvilalage
WCSA
ASEAN BOOK OF RECORDSASIA BOOK OF RECORDS
CAMBODIA BOOK OF RECORDSWorld Records University
worldmark